Telomerase activity and oncogenesis in giant cell tumor of bone.

Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG
Cancer. 1995 75 (5): 1094-9

PMID: 7850706 · PMCID: PMC6712575 · DOI:10.1002/1097-0142(19950301)75:5<1094::aid-cncr2820750507>;2-b

BACKGROUND - Benign giant cell tumor of bone (GCT) is a primary skeletal neoplasm with an unpredictable pattern of biologic aggressiveness and cytogenetic findings characterized by telomeric associations and telomeric reduction. The role of maintaining telomeric integrity is performed by telomerase. To determine if telomerase activity is present, cell extracts from fibroblasts and tumor cells from five patients with GCT were analyzed and compared with HeLa (a positive control cell line).

METHODS - Telomerase activity was detected by visualizing the extension of radioactive telomeric repeats on DNA sequencing gels. Telomere reduction was assessed using southern blot analyses of the restriction enzyme Hinf I digested DNA with a radio-labeled telomere probe.

RESULTS - Telomerase or telomerase-like activity was detected in the cell extracts from HeLa and tumor cells. However, GCT telomerase activity varied and was less than that observed in HeLa, but no activity was detected from fibroblasts. In addition, telomere reduction was seen in DNA isolated from both HeLa and GCT but not in fibroblasts or age-matched controls.

CONCLUSION - Telomere reduction and telomerase activity may be oncogenic sustaining events required to maintain the transformed phenotype seen in GCT.

MeSH Terms (10)

Adult Autoradiography Blotting, Southern Bone Neoplasms DNA, Neoplasm DNA Nucleotidylexotransferase Female Giant Cell Tumor of Bone Humans Male

Connections (1)

This publication is referenced by other Labnodes entities: